Milton C. Ault III - Sep 14, 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Sep 14, 2021
Transactions value $
$35,404
Form type
4
Date filed
9/16/2021, 06:30 PM
Previous filing
Sep 9, 2021
Next filing
Sep 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $13.5K +5K +0.07% $2.70* 6.72M Sep 14, 2021 By Digital Power Lending, LLC F1
holding ALZN Common Stock 150K Sep 14, 2021 Direct
holding ALZN Common Stock 15M Sep 14, 2021 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 10M Sep 14, 2021 By Ault Life Sciences Fund, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Call Option (right to buy) Purchase $16.8K +180 +150% $93.39 300 Sep 16, 2021 Common Stock 18K $2.50 By Digital Power Lending, LLC F1, F4, F5
transaction ALZN Call Option (right to buy) Purchase $5.1K +200 +100% $25.51* 400 Sep 16, 2021 Common Stock 20K $10.00 By Digital Power Lending, LLC F1, F4
holding ALZN Call Option (right to buy) 500 Sep 14, 2021 Common Stock 50K $5.00 By Digital Power Lending, LLC F1, F4
holding ALZN Call Option (right to buy) 50 Sep 14, 2021 Common Stock 5K $7.50 By Digital Power Lending, LLC F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F4 The security listed is an exchange-traded option contract. Exchange-traded options are immediately exercisable and remain exercisable until expiration.
F5 The options were purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $93.3891. The range of purchase prices on the transaction date was $91.511 to $96.511. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of options purchased at each price.